La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Dyskinesias »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dyskinesia, Drug-Induced < Dyskinesias < Dyspepsia  Facettes :

List of bibliographic references indexed by Dyskinesias

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]
Ident.Authors (with country if any)Title
000375 (2016) Leslie Wayne Ferguson [Canada] ; Ali H. Rajput [Canada] ; Alexander Rajput [Canada]Early-onset vs. Late-onset Parkinson's disease: A Clinical-pathological Study.
000474 (2015) Tiago A. Mestre [Canada] ; Isabelle Beaulieu-Boire [Canada] ; Camila C. Aquino [Canada] ; Nicolas Phielipp [États-Unis] ; Yu Yan Poon [Canada] ; Jane P. Lui [Canada] ; Julie So [Canada] ; Susan H. Fox [Canada]What is a clinically important change in the Unified Dyskinesia Rating Scale in Parkinson's disease?
000536 (2015) Philippe Huot [Canada] ; William D. Hutchison [Canada]Serotonin/dopamine transporter ratio as a predictor of L-dopa-induced dyskinesia.
000707 (2015) Isabelle Beaulieu-Boire [Canada] ; Alfonso Fasano [Canada]Graft-induced dyskinesias fail to respond to 5HT1A agonist in the long-term.
000871 (2014) Olivier Rascol [France] ; Susan Fox [Canada] ; Fabrizio Gasparini [Suisse] ; Christopher Kenney [États-Unis] ; Thérèse Di Paolo [Canada] ; Baltazar Gomez-Mancilla [Canada]Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias.
001191 (2012) Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Ahmed Aman ; Susan H. Fox ; Jonathan M. BrotchieL-745,870 reduces L-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
001557 (2011) L K Prashanth [Canada] ; Susan Fox ; Wassilios G. Meissnerl-Dopa-induced dyskinesia-clinical presentation, genetics, and treatment.
001673 (2011) Kaitlyn P. Roland [Canada] ; Jennifer M. Jakobi ; Colin Powell ; Gareth R. JonesFactors related to functional independence in females with Parkinson's disease: a systematic review.
001A35 (2010) Thilo Van Eimeren [Canada] ; Ferdinand Binkofski ; Carsten Buhmann ; Johann Hagenah ; Antonio P. Strafella ; Peter P. Pramstaller ; Hartwig R. Siebner ; Christine KleinImaging movement-related activity in medicated Parkin-associated and sporadic Parkinson's disease.
001D50 (2009) Anthony E. Lang [Canada]When and how should treatment be started in Parkinson disease?
001E02 (2009) A R Troiano [Canada] ; R. De La Fuente-Fernandez ; V. Sossi ; M. Schulzer ; E. Mak ; T J Ruth ; A J StoesslPET demonstrates reduced dopamine transporter expression in PD with dyskinesias.
002308 (2008) Susan H. Fox [Canada] ; Anthony E. Lang [Canada]Levodopa‐related motor complications—Phenomenology
002958 (2005) J E Nash [Canada] ; T H Johnston ; G L Collingridge ; C C Garner ; J M BrotchieSubcellular redistribution of the synapse-associated proteins PSD-95 and SAP97 in animal models of Parkinson's disease and L-DOPA-induced dyskinesia.
002962 (2005) Leonardo Cortese [Canada] ; Michael P. Caligiuri ; Ashok K. Malla ; Rahul Manchanda ; Jatinder Takhar ; Raj HaricharanRelationship of neuromotor disturbances to psychosis symptoms in first-episode neuroleptic-naive schizophrenia patients.
002A57 (2005) Julie-Christine Lévesque [Canada] ; André Parent [Canada]GABAergic interneurons in human subthalamic nucleus
002A62 (2005) Ronald B. Postuma [Canada] ; Tamara Arenovich [Canada] ; Anthony E. Lang [Canada]Does severity of Parkinson's disease vary according to season?
002C61 (2004) Fre De Ric Calon ; Mehdi Dridi ; Oleh Hornykiewicz [Autriche] ; Paul J. Be Dard [Canada] ; Ali H. Rajput ; The Re Se Di PaoloIncreased adenosine A2A receptors in the brain of Parkinson’s disease patients with dyskinesias
002E96 (2003) W. R. Wayne Martin [Canada] ; Marguerite Wieler [Canada]Treatment of Parkinson's disease
002E98 (2003) Pierre J. Blanchet [Canada]The fluctuating Parkinsonian patient: Clinical and pathophysiological aspects
003363 (2000) Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
003476 (2000) P K Pal [Canada] ; A. Samii [Canada] ; A. Kishore [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; S. Yardley [Canada] ; I M Turnbull [Canada] ; D B Calne [Canada]Long term outcome of unilateral pallidotomy: follow up of 15 patients for 3 years

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Dyskinesias" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Dyskinesias" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Dyskinesias
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022